| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 392 | 2017 |
| p53 gene mutations and protein accumulation in human ovarian cancer. J Kupryjańczyk, AD Thor, R Beauchamp, V Merritt, SM Edgerton, DA Bell, ... Proceedings of the National Academy of Sciences 90 (11), 4961-4965, 1993 | 391 | 1993 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 307 | 2015 |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 238 | 2016 |
| Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types SP Kar, J Beesley, A Amin Al Olama, K Michailidou, J Tyrer, ZS Kote-Jarai, ... Cancer discovery 6 (9), 1052-1067, 2016 | 188 | 2016 |
| Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 178 | 2013 |
| A novel germline PALB2 deletion in Polish breast and ovarian cancer patients A Dansonka-Mieszkowska, A Kluska, J Moes, M Dabrowska, ... BMC medical genetics 11, 1-9, 2010 | 141 | 2010 |
| Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study JS Ong, G Cuellar-Partida, Y Lu, Australian Ovarian Cancer Study, ... International journal of epidemiology 45 (5), 1619-1630, 2016 | 138 | 2016 |
| Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31 J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ... Nature communications 4 (1), 1627, 2013 | 136 | 2013 |
| Genome-wide significant risk associations for mucinous ovarian carcinoma Australian Ovarian Cancer Study Group, H Baker, EV Bandera, Y Bean, ... Nature genetics 47 (8), 888-897, 2015 | 116 | 2015 |
| PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients IK Kolasa, A Rembiszewska, A Felisiak, I Ziolkowska-Seta, M Murawska, ... Cancer biology & therapy 8 (1), 21-26, 2009 | 115 | 2009 |
| Shared heritability and functional enrichment across six solid cancers X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ... Nature communications 10 (1), 431, 2019 | 114 | 2019 |
| Ovarian small cell carcinoma of hypercalcemic type–evidence of germline origin and smarca4 gene inactivation. A pilot study J Kupryjańczyk, A Dansonka-Mieszkowska, J Moes-Sosnowska, ... Polish Journal of Pathology 64 (4), 238-246, 2013 | 109 | 2013 |
| Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease. J Kupryjanczyk, AD Thor, R Beauchamp, C Poremba, RE Scully, ... Modern pathology: an official journal of the United States and Canadian …, 1996 | 107 | 1996 |
| BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers HD Meeks, H Song, K Michailidou, MK Bolla, J Dennis, Q Wang, ... Journal of the National Cancer Institute 108 (2), djv315, 2016 | 103 | 2016 |
| Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen J Kupryjańczyk, T Szymańska, R Mądry, A Timorek, J Stelmachow, ... British journal of cancer 88 (6), 848-854, 2003 | 102 | 2003 |
| PTEN mutation, expression and LOH at its locus in ovarian carcinomas. Relation to TP53, K-RAS and BRCA1 mutations IK Kolasa, A Rembiszewska, A Janiec-Jankowska, ... Gynecologic oncology 103 (2), 692-697, 2006 | 98 | 2006 |
| p53 Expression in Ovarian Borderline Tumors and Stage I Carcinomas J Kupryjanczyk, DA Bell, DW Yandell, RE Scully, AD Thor American journal of clinical pathology 102 (5), 671-676, 1994 | 93 | 1994 |
